MedTrace Logo

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

NCT00218179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-01-23

No results posted yet for this study

Summary

Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 known carcinogens. Biomarkers that quantify carcinogen levels and metabolism are a useful tool and available to use. The purpose of this study is to assess the link between tobacco smoke carcinogen biomarkers and the risk of developing lung cancer.

Conditions

Interventions

OTHER

Non-intervention

Measured total NNAL and PheT as biomarkers of exposure

Sponsors & Collaborators

Principal Investigators

  • Timothy Church, Ph.D. · University of Minnesota

Eligibility

Min Age
55 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00218179 on ClinicalTrials.gov